Announced Thu, 9 Jul · 15:19 IST
Routine compliance certificate filed for Q1 FY27 dematerialization
Compliance View source PDF
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹24.00
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.0+1.6+0.0+1.6-0.8+0.8————
Up moveDown movePending
AI summary
Balaxi Pharmaceuticals submitted a certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. Its Registrar and Share Transfer Agent, Aarthi Consultants Private Limited, confirmed it completed all required actions within 15 days of receiving share certificates from depository participants for dematerialization during April to June 2026. These include mutilating and cancelling physical certificates and updating the depository's name as the registered owner in company records.
Likely market impact
Standard quarterly compliance filing with no material effect on shareholders or stock price.